US Patent 11234976 Methods of using pyruvate kinase activators
Patent 11234976 was granted and assigned to Agios Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+94 characters)
Article
Patent abstract
Described herein are methods for using compounds that activate pyruvate kinase.
Edits on 15 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Bruce A. Silver0
Charles Kung0
Elizabeth A. Merica0
Hua Yang0
Lenny Dang0
Marvin B. Cohen0
Samuel V. Agresta0
Yue Chen0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Patent Citations
Edits on 27 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112349760
Date of Patent
February 1, 2022
0Patent Application Number
157350360
Date Filed
June 10, 2016
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 11234976 Methods of using pyruvate kinase activators
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11234976
Date of patent
February 1, 2022
Patent application number
15735036
Date Filed
June 10, 2016
Patent citations
Patent primary examiner
Find more entities like US Patent 11234976 Methods of using pyruvate kinase activators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
